The European Partnership for Personalised Medicine, EP PerMed, supported by the European Union under Horizon Europe, Grant Agreement N° 101137129, has launched its second joint transnational call (JTC2025) for proposals on “Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)”. In total, 35 funding organisations participate in this call with an available budget of over 36.5 Mio. € (approx.).
EP PerMed funding organisations have agreed to jointly fund multinational innovative research projects in personalised medicine (PM), which should bring together academic, clinical/public health and private research teams, thus enhancing the competitiveness in Europe in this field.
The call will be implemented in two stages, i.e. a pre- and a full-proposal phase.
| 09 January 2025 | JTC2025 information day |
| 18 February, 2025 (14:00, CET) | Deadline for pre-proposal submission |
| Expected around 15 May, 2025 | Communication of the results of the pre-proposal assessment and invitation to the full-proposal stage |
| 17 June, 2025 (14:00, CEST) | Deadline for full-proposal submission |
| Mid/end of August 2025 | Rebuttal stage |
| Expected for October 2025 | Communication of the funding decisions to the ap-plicants |
| End of 2025, beginning of 2026 | Expected project start (according to region-al/national funding regulations) |
Call Documents
The call text and all additional documents can be downloaded below: